- Home
- KRMD vs IKT Comparison
KRMD vs IKT Comparison
Compare KRMD & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- IKT
- Stock Information
- Founded
- KRMD 1980
- IKT 2008
- Country
- KRMD United States
- IKT United States
- Employees
- KRMD N/A
- IKT N/A
- Industry
- KRMD Medical/Dental Instruments
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- IKT Health Care
- Exchange
- KRMD Nasdaq
- IKT Nasdaq
- Market Cap
- KRMD 134.3M
- IKT 140.5M
- IPO Year
- KRMD N/A
- IKT 2020
- Fundamental
- Price
- KRMD $4.04
- IKT $1.62
- Analyst Decision
- KRMD Strong Buy
- IKT Buy
- Analyst Count
- KRMD 4
- IKT 2
- Target Price
- KRMD $4.63
- IKT $8.00
- AVG Volume (30 Days)
- KRMD 97.1K
- IKT 97.5K
- Earning Date
- KRMD 08-06-2025
- IKT 08-14-2025
- Dividend Yield
- KRMD N/A
- IKT N/A
- EPS Growth
- KRMD N/A
- IKT N/A
- EPS
- KRMD N/A
- IKT N/A
- Revenue
- KRMD $36,848,451.00
- IKT N/A
- Revenue This Year
- KRMD $21.08
- IKT N/A
- Revenue Next Year
- KRMD $16.37
- IKT N/A
- P/E Ratio
- KRMD N/A
- IKT N/A
- Revenue Growth
- KRMD 19.57
- IKT N/A
- 52 Week Low
- KRMD $1.86
- IKT $1.12
- 52 Week High
- KRMD $5.05
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- KRMD 52.91
- IKT 42.55
- Support Level
- KRMD $4.01
- IKT $1.66
- Resistance Level
- KRMD $4.15
- IKT $1.73
- Average True Range (ATR)
- KRMD 0.14
- IKT 0.09
- MACD
- KRMD -0.04
- IKT -0.01
- Stochastic Oscillator
- KRMD 21.74
- IKT 17.32
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.